Literature DB >> 11241573

Bayesian cost-effectiveness analysis from clinical trial data.

A O'Hagan1, J W Stevens, J Montmartin.   

Abstract

A key tool for assessing the relative cost-effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost-effectiveness. Calculations can be performed using readily available Bayesian software. Copyright 2001 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2001        PMID: 11241573     DOI: 10.1002/sim.861

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

Review 1.  Multilevel factorial experiments for developing behavioral interventions: power, sample size, and resource considerations.

Authors:  John J Dziak; Inbal Nahum-Shani; Linda M Collins
Journal:  Psychol Methods       Date:  2012-02-06

Review 2.  The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.

Authors:  Grant H Skrepnek
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes.

Authors:  Gianluca Baio; Pierluigi Russo
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer: based on data from the Medical Research Council LU19 trial.

Authors:  Laura Bojke; Mark Sculpher; Richard Stephens; Wendi Qian; Nick Thatcher; David Girling
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Bayesian decision analysis for choosing between diagnostic/prognostic prediction procedures.

Authors:  John Kornak; Ying Lu
Journal:  Stat Interface       Date:  2011       Impact factor: 0.582

6.  Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modeling.

Authors:  Andrea Manca; Paul C Lambert; Mark Sculpher; Nigel Rice
Journal:  Med Decis Making       Date:  2007-07-19       Impact factor: 2.583

Review 7.  The road not taken: transferability issues in multinational trials.

Authors:  Pepijn Vemer; Maureen P M H Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2013-10       Impact factor: 4.981

8.  The probability of cost-effectiveness.

Authors:  Anthony O'Hagan; John W Stevens
Journal:  BMC Med Res Methodol       Date:  2002-03-11       Impact factor: 4.615

9.  A cost-utility analysis of a rehabilitation service for people living with and beyond cancer.

Authors:  Jeff Round; Baptiste Leurent; Louise Jones
Journal:  BMC Health Serv Res       Date:  2014-11-19       Impact factor: 2.655

10.  Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods.

Authors:  Mohsen Sadatsafavi; Carlo Marra; Shawn Aaron; Stirling Bryan
Journal:  Trials       Date:  2014-06-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.